Litcius/Paper detail

Meta-Analysis of Differentially Expressed Genes in the Substantia Nigra in Parkinson’s Disease Supports Phenotype-Specific Transcriptome Changes

Duong My Phung, Jinwoo Lee, Sangkyoon Hong, Young Eun Kim, Young Eun Kim, Jeehee Yoon, Yun Joong Kim, Yun Joong Kim

2020Frontiers in Neuroscience25 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Studies regarding differentially expressed genes (DEGs) in Parkinson's disease (PD) have focused on common upstream regulators or dysregulated pathways or ontologies; however, the relationships between DEGs and disease-related or cell type-enriched genes have not been systematically studied. Meta-analysis of DEGs (meta-DEGs) are expected to overcome the limitations, such as replication failure and small sample size of previous studies. PURPOSE: Meta-DEGs were performed to investigate dysregulated genes enriched with neurodegenerative disorder causative or risk genes in a phenotype-specific manner. METHODS: -values and combing effect size, and common DEGs were used for secondary analyses. Gene sets of cell type-enriched or disease-related genes for PD, Alzheimer's disease (AD), and hereditary progressive ataxia were constructed by curation of public databases and/or published literatures. RESULTS: Our meta-analyses revealed 449 downregulated and 137 upregulated genes. Overrepresentation analyses with cell type-enriched genes were significant in neuron-enriched genes but not in astrocyte- or microglia-enriched genes. Meta-DEGs were significantly enriched in causative genes for hereditary disorders accompanying parkinsonism but not in genes associated with AD or hereditary progressive ataxia. Enrichment of PD-related genes was highly significant in downregulated DEGs but insignificant in upregulated genes. CONCLUSION: Downregulated meta-DEGs were associated with PD-related genes, but not with other neurodegenerative disorder genes. These results highlight disease phenotype-specific changes in dysregulated genes in PD.

Topics & Concepts

TranscriptomeBiologyGenePhenotypeGeneticsSubstantia nigraCandidate geneParkinsonismDiseaseParkinson's diseaseGene expressionMedicinePathologyParkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingNeurological disorders and treatments